Who backs Ancilia Bio?
13 investors| Investor | Type |
|---|---|
| US National Science Foundation | Other |
| Metaplanet Holdings | Venture capital |
| National Institutes of Health | Other |
| New York Ventures | Venture capital |
| Spacecadet Ventures | Venture capital |
| Safar Partners | Venture capital |
| Snatched Ventures | Venture capital |
| ARPA-H | — |
| Bioverge Ventures | — |
| Deep Science Ventures | — |
| + 3 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Ancilia Bio investors
13 investors are on record for Ancilia Bio, including US National Science Foundation, Metaplanet Holdings, National Institutes of Health and New York Ventures. By type, the record holds 5 venture capital firms. The early-stage round in Apr 2023 drew 2 investors.
Free account
More of Ancilia Bio with a free account
- ·The complete investor list: 13 names
- ·Watch Ancilia Bio: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 13 firms already write checks for companies like Ancilia Bio in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View